KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 55 filers reported holding KALA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $11,000 | -8.3% | 51,716 | +24.8% | 0.00% | – |
Q2 2022 | $12,000 | -99.0% | 41,442 | -75.8% | 0.00% | -100.0% |
Q1 2021 | $1,156,000 | -63.6% | 171,523 | -63.3% | 0.00% | -66.7% |
Q4 2020 | $3,172,000 | +78.8% | 467,902 | +177.2% | 0.01% | 0.0% |
Q2 2020 | $1,774,000 | +769.6% | 168,815 | +627.7% | 0.01% | +350.0% |
Q1 2020 | $204,000 | -27.9% | 23,200 | -59.9% | 0.00% | +100.0% |
Q4 2018 | $283,000 | +164.5% | 57,876 | +432.0% | 0.00% | – |
Q3 2018 | $107,000 | – | 10,879 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 1,430,021 | $9,638,000 | 6.26% |
RA Capital Management | 10,874,613 | $73,295,000 | 1.10% |
Mesirow Financial Investment Management, Inc. | 41,961 | $283,000 | 0.77% |
Samsara BioCapital, LLC | 601,162 | $4,052,000 | 0.75% |
SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $689,000 | 0.38% |
Eventide Asset Management | 3,450,000 | $23,253,000 | 0.34% |
Orbimed Advisors | 5,465,030 | $36,834,000 | 0.34% |
Parkman Healthcare Partners LLC | 148,433 | $1,000,000 | 0.23% |
Vivo Capital, LLC | 786,883 | $5,304,000 | 0.19% |
Knights of Columbus Asset Advisors LLC | 199,954 | $1,348,000 | 0.13% |